Invicta Diagnostic SME IPO
Alloted
Invicta Diagnostics (PC Diagnostics) is a diagnostic chain operating primarily in the Mumbai Metropolitan Region (MMR). The company provides a one-stop solution by offering both radiology (X-ray, CT, MRI, PET CT) and pathology (routine and specialized tests) services through a hub-and-spoke model. The network includes 7 diagnostic centres and 1 centralised laboratory across MMR, ensuring high-end services are accessible. The company focuses on improving customer convenience through home sample collection and multiple report delivery options.
Issue Price
85
Current GMP
₹0 (0.00%)
Overall Subscription
4.27x
Issue Size
₹28.12 Cr
Advertisement
Live Subscription by Application
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 334 | 3 | 0.01x |
FII | - | 0 | - |
DFI | - | 0 | - |
MF | - | 0 | - |
Other | - | 3 | - |
| NII | 113 | 407 | 3.60x |
bNII | 75 | 189 | 2.52x |
Corporate | - | 6 | - |
Individual | - | 183 | - |
Other | - | 0 | - |
sNII | 38 | 218 | 5.74x |
Corporate | - | 7 | - |
Individual | - | 208 | - |
Other | - | 3 | - |
| IND | 396 | 1,363 | 3.44x |
| Total | 843 | 1,773 | 2.10x |
Live Subscription by Shares
| Category | Shares Offered | Shares Applied | Subscription |
|---|---|---|---|
| QIB | 5.34 L | 18.75 L | 3.51x |
FII | - | 0 | - |
DFI | - | 0 | - |
MF | - | 0 | - |
Other | - | 18.75 L | - |
| NII | 5.42 L | 39.41 L | 7.27x |
bNII | 3.62 L | 28.06 L | 7.76x |
Corporate | - | 2.30 L | - |
Individual | - | 25.76 L | - |
Other | - | 0 | - |
sNII | 1.81 L | 11.34 L | 6.27x |
Corporate | - | 33.60K | - |
Individual | - | 10.86 L | - |
Other | - | 14.40K | - |
| IND | 12.67 L | 43.62 L | 3.44x |
| Total | 23.44 L | 1.02 Cr | 4.34x |
Subscription Summary
QIB
Shares Applied:3.51x
Applications Offered:0.01x
NII
Shares Applied:7.27x
Applications Offered:3.60x
IND
Shares Applied:3.44x
Applications Offered:3.44x
Quick Stats
Total Categories3
IPO TypeSME
StatusAllotment Out
Join us on Telegram for instant IPO updates!
Join NowData Last Updated
4 Dec 2025, 01:30 pm
Auto-refreshing
Advertisement
Understanding Subscription Categories
QIB
Qualified Institutional Buyers
Includes FII, DFI, Mutual Funds, and other qualified institutions.
NII
Non-Institutional Investors
High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).
IND
Individual Investors
Individual investors in SME IPOs up to ₹2 lakh.
Frequently Asked Questions
What is the current subscription status of Invicta Diagnostic SME?
The current overall subscription for Invicta Diagnostic SME is 4.27x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Invicta Diagnostic SME subscription status?
You can check Invicta Diagnostic SME subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 1 December 2025 to 3 December 2025.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 4.27x means the IPO received 4.27x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Invicta Diagnostic SME subscription close?
The subscription for Invicta Diagnostic SME closes on 3 December 2025. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Individual (IND) subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Individual (IND) includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 4.27x, it means there are 4.27x times more applications than shares available, making allotment competitive.
When will Invicta Diagnostic SME allotment be finalized?
The allotment for Invicta Diagnostic SME will be finalized and announced on 4 December 2025. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 3 December 2025, the company and registrar process all applications. Allotment is finalized by 4 December 2025, and shares are credited to successful applicants' demat accounts before the listing date on 8 December 2025.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 3 December 2025. All IPO applications must be submitted during the subscription period from 1 December 2025 to 3 December 2025. Late applications are automatically rejected.
What is the issue size and lot size for Invicta Diagnostic SME?
The issue size for Invicta Diagnostic SME is ₹28.12 Cr, and the lot size is 1600 shares. The price range is ₹80.0 - ₹85.0. You must apply in multiples of the lot size.